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MUTAGENESIS TRANSGLUTAMINASE MIKROBIAL 
UNTUK KONJUGASI QTAG-KTAG 
 
ABSTRAK 
Penemuan awal transglutaminase mikrobial (mTGase) adalah untuk 
mengurangkan kos tinggi transglutaminase mamalia dalam aplikasi industri 
pemprosesan makanan. Enzim ini telah menjadi alatan penting dalam aplikasi 
bioteknologi disebabkan sifat tahan lasak, ketulenan yang tinggi, tidak memerlukan 
ion kalsium untuk pengaktifan dan mempunyai kadar tindak balas yang tinggi. Akan 
tetapi, mTGase mempunyai kekhususan substrat yang rendah disebabkan celah tapak 
aktif yang lebar pada enzim telah membantutkan aplikasinya dalam bidang 
bioteknologi. Oleh itu, mutagenesis pada mTGase untuk mendapatkan enzim yang 
substrat spesifik bagi konjugasi spesifik amat diidamkan. Ketiga-tiga residu yang 
penting untuk pengecaman substrat (V65, W69, and Y75) dimutasi kepada 20 jenis 
asid amino untuk pembinaan perpustakaan mutan pertama. Mutasi pada mutan aktif di 
ketiga-tiga residu digabung kepada semua gabungan yang mungkin untuk membina 
perpustakaan mutasi bergabung. Mutan MTG 120 yang memperolehi aktiviti spesifik 
yang tertinggi diguna untuk mengasingkan peptida yang mengandungi glutamin 
dengan sebuah perpustakaan faj peptida 20-mer NNK. MTG 120 dengan mutasi 
leusina (L), metionina (M), dan asid glutamik (E) mempamerkan aktiviti spesifik yang 
paling tinggi. Selain itu, MTG 120 menunjukkan pengurangan yang ketara dalam paut 
silang secara rawak dengan substrat mTGase seperti albumin serum lembu, dan 
fosfatase alkali hasilan makmal. Pengikat afiniti tinggi kepada MTG 120 iaitu faj 
peptida P58 berjaya diasingkan melalui proses ‘biopanning’. Motif RVGQL yang 
berasal daripada peptida P58 yang diasingkan bercantum dengan fosfatase alkali 
xx 
 
hasilan makmal untuk konjugasi dengan scFv antibodi Ubiquitin yang mempunyai tag 
penta-lisina. Konjugasi antara kedua-dua protein itu berjaya menghasilkan jalur yang 
bersaiz kira-kira 85 kDa di Blot Barat. Produk konjugasi tersebut juga menunjukkan 
pengekalan fungsi dengan penetapan kadar immunosorben taut-enzim (ELISA). 
Mutagenesis mTGase bersamaan dengan pengasingan peptida yang spesifik dengan 
mutan telah berjaya memperbaiki kekhususan substrat mTGase untuk aplikasi dalam 
bidang bioteknologi. 
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MUTAGENESIS OF MICROBIAL TRANSGLUTAMINASE 
FOR QTAG-KTAG CONJUGATION 
 
ABSTRACT 
The initial discovery of microbial transglutaminase (mTGase) was to soothe 
the high cost of mammalian transglutaminase in food processing industries. This 
enzyme has become an important tool in biotechnological applications due to its 
robustness, availability in high purity, bypass the need of calcium ions for activation 
and high reaction rate. However, mTGase has low substrate specificity due to its wide 
active site cleft which impeding its diverse applications in biotechnological use. 
Therefore, mutagenesis of mTGase to obtain substrate specific enzyme is highly 
desirable for site-specific conjugations. Three residues (V65, W69, and Y75) that are 
crucial for substrate recognition were mutated to all 20 amino acids to generate the 
first mutant library. Mutations at respective sites of the active mutants were then 
combined at all possible combinations to construct the combinatorial mutant library. 
MTG 120 mutant with the highest specific activity was used to pan against a 20-mer 
NNK peptide phage library to isolate glutamine-containing peptide. MTG 120 with 
mutations of leucine (L), methionine (M), and glutamic acid (E) at residue 65, 69, and 
75, respectively, exhibited the highest specific activity. Also, MTG 120 showed 
significant reduction in random cross-linking with mTGase substrates including 
bovine serum albumin, and in-house alkaline phosphatase. A high affinity binder 
against MTG 120, peptide phage P58 has been successfully isolated through 
biopanning process. The motif RVGQL derived from the isolated peptide P58 was 
fused with in-house alkaline phosphatase to perform conjugation with penta-lysine tag 
anti-Ubiquitin scFv. The two proteins were successfully showed conjugation in 
xxii 
 
Western blot to give a band around 85 kDa. The conjugated product also showed 
retained of functionality in enzyme-linked immunosorbent assay (ELISA). 
Mutagenesis of mTGase coupled with selection of mutant specific peptide has 
successfully improved the substrate specificity of mTGase for applications in 
biotechnological fields. 
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CHAPTER 1 
INTRODUCTION 
1.1 Literature Review  
The inherent ability to bring molecules together and allowing them to stay with 
each other requires many factors to be taken into consideration. The design and 
modifications required to achieve such as feat is an art form on its own. In the field of 
medical biotechnology, the target molecules are usually either DNA or proteins. The 
biomolecules are unique in the way they function, fold and regulate mechanisms in 
biological systems. However, the advent of recombinant DNA technology has allowed 
these molecules to serve a greater function via evolutionary reprogramming. The move 
towards “greener” approaches when dealing with biomolecules is critical in this aspect 
as harsh modification strategies risk the disruption and destruction of the conjugated 
biomolecules in terms of stability and function. Therefore protein conjugation is an 
area of study which is critical to supplement the ever evolving field of medical 
biotechnology. 
1.1.1 Protein Conjugation  
Conjugation is a process of joining independent molecules together covalently to 
achieve a hybrid molecule with combined attributes of each individual components. 
This is done to attain better functional properties including biocompatibility, 
biostability, and bioselectivity of the hybrid molecule for various biomedical 
applications (Koniev and Wagner, 2015). Protein and peptide conjugates especially 
have been intensively studied due to their high potentials in the biomedical field (van 
Hest, 2017). Various conjugation strategies have been developed over the years for 
protein conjugations to generate well-defined conjugates (Boutureira and Bernardes, 
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2015). Generally, protein conjugation strategies can be divided to two major groups: 
chemical conjugation, and enzymatic conjugation. 
 
1.1.1 (a) Chemical Conjugation  
 Chemical protein conjugation methods generally employ lysine (Lys) or cysteine 
(Cys) residues due to their high nucleophilicity in the side chains (Chalker et al., 2009). 
Lysine has an accessible primary amine group to act as a good nucleophile for a broad 
range of organic reactions (Basle et al., 2010). The nucleophilicity of the amine group 
of Lys residue to react with electrophiles to form a bond with amine group is higher 
and faster than other amino acids (Brun and Gauzy-Lazo, 2013). Also, the abundance 
of Lys residues on the protein surface makes them sufficiently exposed or accessible 
for reaction (Brun and Gauzy-Lazo, 2013, Sesay, 2003). N-hydroxyl-succinimidyl 
(NHS) ester is the common reagent used in Lys conjugation to form amide bonds 
between the carboxylic acid and amino group due to its simplicity and availability 
(Basle et al., 2010).  
The Cys residue is another common site targeted for protein conjugation owing to 
its high nucleophilicity at its thiol (-SH) side chain (Brotzel and Mayr, 2007). At pH 
levels below 9, amine gets protonated and the thiol group becomes more nucleophilic 
than amine, resulting in a faster reaction in Cys over Lys residues (Basle et al., 2010). 
Albeit taking part in most of the functional properties, Cys is low in abundance in 
proteins which allows better manipulation in conjugation compared to Lys residues 
(Kim et al., 2015, Koniev and Wagner, 2015). Pre-treatment with dithiothreitol (DTT) 
is required to free the thiol groups for tagging because thiol groups are often found in 
disulphide form (Crankshaw and Grant, 2001). 
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Notwithstanding the promising results of chemical conjugation over the years, 
many more setbacks regarding this group of conjugation techniques are being reported. 
For example, Lys conjugation requires high pH values to avoid protonation of the 
amine group which greatly decrease its reactivity. Protonated amine groups under 
physiological pH demonstrates no significant nucleophilicity compared to other side 
chain groups (Koniev and Wagner, 2015). That being said, chemical conjugation might 
not be ideal for alkaline sensitive proteins (Basle et al., 2010). Often, chemical 
conjugations cause heterogeneity in products due to the presence of multiple Lys or 
Cys sites distribute in protein (Dennler et al., 2015b). Presence of heterogeneous 
products is particularly unfavourable in antibody-drug conjugates (ADCs). This is 
because it can increases the likelihood for unconjugated antibodies to compete with 
conjugated antibodies for antigen binding sites which can weaken the therapeutic 
index (Junutula et al., 2008). Moreover, NHS esters have low specificities due to their 
reactions with random amino acids to form labile bonds which produce undesired side 
products (Chih et al., 2011). Despite the widespread use of chemical conjugation, 
emphasis on production of homogeneous conjugated products has been growing. 
Especially in the biopharmaceutical industry, payload distribution is exceptionally 
essential for conjugate stability and efficacy (Sochaj et al., 2015). In order to 
complement existing chemical conjugation approaches, efforts have been driven to 
address these problems with alternatives such as enzymatic conjugation.  
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1.1.1 (b) Enzymatic Conjugation  
Evolution of Chemical Biology over the decades has seen to increased use of 
enzymes to form defined covalent bonds leading to the production of compounds with 
novel compositions (McFarland and Rabuka, 2015). The advantage of this approach is that 
further modification in natural amino acid residues for enzymatic conjugation is not 
required. The introduction of an enzyme recognizable motif with the target protein for co-
expression allows conjugation to take place subsequently (Agarwal and Bertozzi, 2015, 
Appel and Bertozzi, 2014). With the aid of recombinant technology, the required motif 
could be easily introduced to the target protein by cloning without hassle (Dennler et 
al., 2015b). 
Enzymes like sortase A (srtA), transglutaminase (TGase) and formylglycine-
generating enzyme (FGE) have shown promising applications in mediating enzymatic 
protein conjugation for various industrial applications. TGase is unique in comparison to 
srtA and FGE as the later two enzymes are capable of recognising a specific motif for 
conjugation but not TGase. Sortase A (EC 3.4.22.70) is a calcium-dependent 
transpeptidase which recognises LPXTG motif where ‘X’ can be any of the naturally 
occurring amino acids. As shown in Figure 1.1A, the thiol group of srtA (Cys184) attacks 
the amide bond between threonine (T) and glycine (G) in the LPXTG motif by cleaving it 
to form thioacyl intermediate.  
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Figure 1.1: Enzymatic conjugation approaches. (A) Sortase A (SrtA). Protein A has 
LPXTGXn motif near the C-terminal to form intermediate with Sortase A. Then, the 
acyl-enzyme intermediate was resolved by nucleophile poly-glycine tagged at N –
terminal of Protein B to release the enzyme and conjugated product. (B) 
Formylglycine-generating enzyme (FGE) oxidises the cysteine to formylglycine 
(FGly). (C) Microbial transglutaminase (mTGase). Isopeptide bond was formed 
between acyl donor (Protein A) and amine group of acyl acceptor (Protein B) which 
catalysed by mTGase. 
A 
C 
B 
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A second wave of nucleophilic attack by the glycine residues in the poly-glycine 
linker found in the coupling partner releases the intermediate to generate a new amide bond 
between the LPXTG bound target and poly-glycine tagged partner (Mazmanian et al., 1999, 
Schumacher et al., 2016). FGE (E.C. 1.8.99.-) on the other hand oxidises a cysteine 
residue in the conserved sequence of CXPXR found in eukaryotes or serine residue in 
SXPXR of prokaryotes to an active formylglycine (FGly) (Figure 1.1B). The ‘X’ in 
the conserved motifs are recognisable either as serine, threonine, alanine or glycine 
(Carrico et al., 2007). Introduction of the FGE recognisable motif into a desired protein 
allows the protein to co-express with the aldehyde tag which can be used for 
conjugation using aminooxy or hydrazine-functionalised reagents (Rashidian et al., 
2013). Different from srtA and FGE, TGase is able to cross-link proteins randomly 
without  the need of a consensus sequence making them extensively studied (Milczek, 
2017). 
  The term transglutaminase (TGase) was first coined in year 1959 to describe 
the transamidating activity observed in guinea-pig liver (Clarke et al., 1959). 
Transglutaminases (protein-glutaminase γ-glutamyltransferase EC 2.3.2.13) are 
transferases that catalyse the transfer of acyl groups between γ-carboxyamide groups 
in glutamine (Glu) residues and primary ε-amino groups in residues such as lysine 
(Lys). Glutamine residues act as acyl donors and various primary amines acts as acyl 
acceptors to form covalent isopeptide bonds between these two residues which results 
in protein cross-linking (Figure 1.1C) (Griffin et al., 2002, Ohtsuka et al., 2000a). 
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TGases are widely found in different taxonomic groups such as 
microorganisms (Ando et al., 1989), plants (Del Duca et al., 2014), animals (Folk and 
Cole, 1966) and humans (Suedhoff et al., 1990). Generally, TGases require calcium 
(Ca2+) ions for activation. Upon binding, Ca2+ ions function to expose two key residues 
near the active site which are vital for substrate access (Ahvazi et al., 2002). In animals 
or humans, TGases are inactive under normal physiological conditions and can only 
be activated when Ca2+ ions bind during the disruption of physiological homoeostatic 
mechanisms (Griffin et al., 2002). However, the requirement of Ca2+ ions for activation 
in plants are not absolute (Lorand and Graham, 2003, Serafini-Fracassini et al., 1995). 
On the other hand, microbial transglutaminse (mTGase) is a calcium-independent 
TGase which was first isolated from Streptomyces mobaraensis (formerly known as 
Streptoverticillium mobaraense) by a researcher from Ajinomoto Co., Inc (Ando et al., 
1989). Different bacterial strains including Streptomyces sp. have been studied for the 
production of mTGase. However, Streptomyces sp. has significantly better yield 
compared to other strains which makes it the most preferred source in the industry to 
produce mTGase (Zhang et al., 2009).  
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1.1.2 Microbial Transglutaminase  
1.1.2 (a) Characterisations of mTGase  
Recombinant mTGase are commonly expressed in a zymogen form (pro-MTG) 
to avoid detrimental internal cross-linking of essential cytosolic proteins (Takehana et 
al., 1994). A 45-residue pro-sequence 
(DNGAGEETKSYAETYRLTADDVANINALNESAPAASSAGPSFRAP) located at 
the N-terminal of mTGase is reported to fold into an α-helix adopting a L-shape 
conformation which covers the enzyme active site as shown in Figure 1.2 (Yang et al., 
2011).  
 
 
Figure 1.2: Crystal structure of mTGase from S. mobaraensis. (Left) PDB ID 3IU0: 
The 45-residue pro-sequence  is fold into an α-helix covering the active site (Cys64) 
(Yang et al., 2011). (Right) PDB ID 1IU4: Active form of mTGase exposing the active 
site (Cys64) that is vital for activity (Kashiwagi et al., 2002). 
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The pro-sequence is vital for enzyme folding and inhibition of enzyme activation 
within the cells. Removal of the pro-sequence using proteases reveal the active site of 
the enzyme to initiate the function. This allows for a turn-on / turn-off switch to be 
introduced via enzyme treatment. Examples of proteases reported to activate pro-MTG 
include trypsin, dispase, chymotrypsin, transglutaminase activating metalloprotease 
(TAMEP), thrombin, cathepsin B, and proteinase K (Eder and Fersht, 1995, Pasternack 
et al., 1998, Marx et al., 2008a).   
The complete amino acid sequence of the activated mTGase derived from 
Streptomyces sp. has been characterised to consist of 331 amino acids with a molecular 
weight of approximately 38  kDa with an isoelectric point of 8.9 (Kanaji et al., 1993). 
It is reported to be a monomeric, simple protein, with no known glycosylation or lipids  
(Yokoyama et al., 2004). Also, mTGase exhibits good stability over a wide range of 
temperature and pH compared to other sources of TGases (Yokoyama et al., 2004). Up 
till today, two crystal structures of mTGase from Streptomyces mobaraensis have been 
deposited in Protein Data Bank (PDB) including PDB ID: 1U14 (Kashiwagi et al., 
2002), and PDB ID: 3IU0 (Yang et al., 2011). Microbial transglutaminase is suggested 
to have a novel three-dimensional structure due to the fact that no similar proteins to 
mTGase could be found. Both crystal structures showed mTGase folds into a plate-
like shape with a deep cleft at the edge of the molecule which is distinct from factor 
XIII-like TGases that adopts protease-like catalytic triad structures (Kashiwagi et al., 
2002, Yang et al., 2011).  
Structurally, a single cysteine (Cys64) residue has been identified in mTGase 
residing at the bottom cleft of the crystal structure. The Cys64 comes in proximity with 
aspartic acid (Asp255) and histidine (His274) residues to form the active site which 
superimposes well on a catalytic triad (Kashiwagi et al., 2002). Despite the catalytic 
10 
 
triad of mTGase being able to superimpose well with factor XIII-like TGases, studies 
showed mTGase are capable of generating higher reaction rates (Shimba et al., 2002). 
This is associated to the Cys64 residue of mTGase which is exposed to surrounding 
solvent allowing the reaction of mTGase with substrates to promptly occur. In addition 
to that, the flexibility of the right side wall of the active site cleft reduces the steric 
hindrance between the substrates and enzyme allowing improved accessibility 
(Kashiwagi et al., 2002). Another exciting attribute of mTGase is the broad substrate 
specificity for acyl donors. This unique attribute can be explained by the crystal 
structure of mTGase which reveals the wide active-site cleft position that 
accommodates the α-helix pro-sequence. The wide size of the active-site allows for 
additional flexibility in the active-site to accommodate a less specific substrate 
(Shimba et al., 2002). This explains the broad specificity of mTGase to react with a 
large family of acyl donors. This flexibility and efficacy has allowed mTGase to 
contribute efficiently to many different applications in various industries making it a 
vital enzyme in industry. 
 
1.1.2 (b) Applications of mTGase 
The low substrate specificity of mTGase allows it to effectively cross-link most of 
the proteins it comes in contact with post-activation. This unique feature of mTGase 
has been exploited in various industries such as food, textile, and leather processing to 
improve their functional properties (Mariniello and Porta, 2005). However, 
bioavailability of isopeptide moieties in native proteins and protein structures will 
affect the affinity of mTGase to these proteins (Matsumura et al., 1996). In the meat 
industry, mTGase is used to restructure meat by mixing mTGase with caseinate as a 
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substituent to salts and phosphates that can be used in conventional meat binding and 
texturing. When reacted with mTGase, caseinate becomes viscous allowing the meat 
pieces to stick together. Restructuring meat with different types of meat offer better 
texture as compared to one-meat product due to the availability of isopeptide bonds in 
different meats (Zhang et al., 2009). In dairy products and soy proteins, mTGase is 
applied to improve characteristics such as gelling strength and viscosity (Gan et al., 
2009b, Kuraishi et al., 2001). In wool and textile industries, mTGase is used to recover 
the damage of wool caused by proteolytic treatment of protease in biological 
detergents. Also, it is used to enhance the tensile strength of wool fibers. In leather 
processing industries, mTGase is applied in the filling step where the voids in the fibers 
of leather can be sealed (Tesfaw and Assefa, 2014). 
The early discovery of mTGases was meant to replace the animal derived TGases 
in food industries. Since then, mTGase has surged on to become an impeccable tool in 
the biotechnology field. Many publications showed the utilization of mTGase in 
conjugation processes for biotechnological applications (Dennler et al., 2014, Lin and 
Ting, 2006, Spolaore et al., 2016, Strop et al., 22 Nov 2012). A recent publication 
summarized the research and biotechnological applications of mTGase for the 
conjugation of proteins with proteins, DNA, polymers, and radioisotopes (Strop, 2014).  
Conjugation of different moieties together using mTGase mostly depends on the 
glutamine-tag (Qtag) and lysine-tag (Ktag) since mTGase does not show any 
preference towards specific peptide sequences. As long as both lysine (K) and 
glutamine (Q) residues are accessible to mTGase, they could serve as potential 
substrates for protein conjugation to occur (Coussons et al., 1992). A variety of Qtag 
DNA conjugation with Ktag protein by mTGase has been reported over the years 
(Takahara et al., 2013, Tominaga et al., 2007). Also, various other molecules could be 
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conjugated with proteins like antibodies simply by the introduction of a Ktag and Qtag 
which are recognized by mTGase (Kamiya et al., 2003a, Lee et al., 2013, Lin and Ting, 
2006). Qtag single-chain fragment variable (scFv) was successfully fused to a Ktag 
enhanced yellow fluorescent protein (EYFP) to yield a heterodimer (scFv-EYFP 
fusion protein) product by mTGase. Validation of this fusion protein with fluorescent 
immunoassay (FIA) confirmed the functionality of both proteins was intact post-
conjugation (Kamiya et al., 2003a). In a separate study, mTGase conjugation 
demonstrated higher specificity compared to chemical modifications for 
immobilisation of Ktag alkaline phosphatase onto casein-coated polyacrylic resin. 
This technique created a stable functional protein array which is crucial for 
biotechnological applications (Tominaga et al., 2004a). The versatility of mTGase in 
conjugation was challenged when myc-tag (EQKLISEEDL) was exploited as the acyl 
donor to conjugate various moieties including antibodies, biotin, fluorescent dye, 
radioisotopes, chemical functional group and surface. The group successfully 
conjugated all tested functionalities which could be potentially used for various 
applications (Dennler et al., 2015a). 
The ability of mTGase to conjugate proteins easily has been harnessed in the 
biopharmaceutical industry to produce antibody drug conjugates (ADCs) (Dorywalska 
et al., 2015, Farias et al., 2014, Strop et al., 2016). However, researchers observed 
mTGase only recognize glutamine residues (Q295) in constant regions of aglycosylated 
or deglycosylated antibodies but not those in glycosylated antibodies (Jeger et al., 2010, 
Mindt et al., 2007, Strop et al., 22 Nov 2012). Presence of N-glycan at N297 hinders 
the transamination of mTGase due to steric hindrance. Removal of N-glycan at N297 
using Peptide-N-Glycosidase (PNGase F) allows Q295 more accessibility to mTGase 
and enhances the flexibility of the loop where the residue is located (Jeger et al., 2010). 
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The work was extended to conjugate different moieties including antimitotic toxin 
monomethyl auristatin E (MMAE) and radioactive substrates (67Ga and 89Zr) to 
antibodies using the similar strategy (Jeger et al., 2010, Dennler et al., 2014). Later, 
researchers developed a glutamine tag (LLQG) that can be engineered at desired 
locations of the antibody after performing a systematic scan of the constant domains. 
The introduction of amine containing linkers would allow mTGase to conjugate 
various probes and drugs including fluorophores and potent tubulin inhibitor (MMAD) 
to antibodies with similar efficiencies across all antibody subtypes (Strop et al., 2013). 
Despite the low substrate specificity of mTGase, applications of mTGase in various 
fields have conferred the advantages of mTGase based conjugations.  
 
1.1.2 (c) Advantages of mTGases Based Conjugations 
Microbial transglutaminase provides a convenient approach for protein 
conjugation without major modifications to the natural amino acid residues. Peptide 
tags can be cloned directly with the protein of interest for co-expression prior to 
conjugation (Agarwal and Bertozzi, 2015, Appel and Bertozzi, 2014). Moreover, 
mTGase recognisable motifs are usually short (about 5-6 amino acids) which will not 
interfere with the expression, purification and function of the proteins. Complications 
regarding immunogenicity triggered by peptides could also be minimized (Hagemeyer 
et al., 2015). As mentioned earlier, mTGase provides a promising alternative for 
conjugation because it does not interfere with antigen binding. Also, the mild 
conjugation condition of mTGase helps to reserve the intact functionalities of the 
conjugated proteins (Kamiya and Mori, 2015, Swee et al., 2013, Wu et al., 2009). This 
is an added advantage over chemical conjugation methods as the use of glutaraldehyde 
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has been reported to impair antigen conformation when used at a higher percentages 
(Chan and Lim, 2016). However, this is not a concern when conjugating proteins using 
mTGase (Strop, 2014).  
Conjugation of mTGase is irreversible unlike srtA which is also another 
favourite workhorse for protein conjugation. Despite its high specificity, the reversible 
reaction of srtA requires the need for a higher enzyme concentration for efficient 
conjugation (Chen et al., 2011, Rashidian et al., 2013). Other advantages of mTGase 
is the lower cost of production (Yurimoto et al., 2004) and its ability to avoid red 
pigmentation in food products unlike animal derived TGases. Red pigmentation of 
animal TGases causes detrimental changes to the appearance of the product making it 
unsuitable for sale (Yokoyama et al., 2004, Zhang et al., 2009). Furthermore, mTGase 
exhibits a higher activity which is crucial for large scale production and enzymatic 
conjugation (Steffen et al., 2017). Importantly, mTGase have broad substrate 
specificity, calcium independence, and is stable over a wide range of temperature and 
pH making it ideal for the conjugation of various substrates (Kuraishi et al., 2001, Zhu 
et al., 1995). The broad substrate specificity of mTGases is very useful in food and 
textile industries to catalyse random amide bond formation (Gundersen et al., 2014). 
However, it is a huge challenge when site-specific conjugation is desired since 
mTGases randomly cross-links with non-target substrates (Steffen et al., 2017, Strop, 
2014). In order to overcome these issues, various approaches including mutagenesis 
and phage display biopanning were then taken to address the substrate preference of 
mTGases with the hopes of improving its specificity and functionality (Sugimura et 
al., 2008, Yokoyama et al., 2010). 
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1.1.3 Enzyme Engineering  
1.1.3 (a) Strategy and Techniques for Enzyme Engineering 
In nature, enzymes naturally aid in sustaining the development of organisms in a 
natural environment. Therefore, natural enzymes usually are not equipped with 
adequate properties to be utilised for biotechnological applications (Fernandez-Gacio 
et al., 2003). The generation of enzymes with desired properties like thermostability, 
bioactivity, and specificity has ushered in the development of enzyme engineering 
which serves as a powerful tool to improve enzyme performance (Denard et al., 2015, 
Dalby, 2011). Generally, strategies for enzyme engineering are divided as the rational 
method, random method (directed evolution) and the semi-rational method which is a 
combination of both random and rational approaches (Steiner and Schwab, 2012). In 
the rational method, replacement of amino acids at precise locations are designed 
based on the knowledge of protein structure and mechanism information (Steiner and 
Schwab, 2012). In comparison with the rational method, similar information and 
knowledge of the protein are not required in the random method approach. The 
approach employs a random process such as error-prone PCR to create a mutant library 
(Chen, 2001). Both the rational and random methods have their own pros and cons but 
yet they can work to complement each other. The rational method requires the 
generation of a smaller library size, hence less effort and time is required for screening. 
The random method on the other hand introduces mutations randomly without  bias 
yielding a large mutant library which would require the need to screen large numbers 
of mutants (Tachioka et al., 2016). Meanwhile the semi-rational approach combines 
the advantages from both rational and random methods requiring a smaller size library 
based on protein biochemical and structural data (Steiner and Schwab, 2012) where 
specific residue sites are determined ‘rationally’ and then randomized to all 20 amino 
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acids (McLachlan et al., 2009). The library is then screened to yield the desired 
mutants.  
Site-directed mutagenesis (SDM) is commonly used for rational method amino 
acid substitution, addition, or deletion in the template DNA sequence (Urban et al., 
1997). Overlap-extension PCR (OE-PCR) is often described as the approach to 
perform SDM to introduce desired mutations. In OE-PCR, two separate PCRs are 
performed to generate two separate DNA fragments with similar overlapping ends by 
using 4 primers (Figure 1.3).  
 
Figure 1.3: Overlap-extension PCR (OE-PCR) for site-directed mutagenesis. Primer 
1 and 4 is MTG outer forward and reverse primer respectively. Primer 2 and 3 is 
respective reverse and forward primer carrying desired mutation. 
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The desired mutations are introduced at this stage. Later, these two DNA fragments 
are heat denatured and joined via PCR to generate the whole DNA fragment with a set 
of outermost primers (Antikainen and Martin, 2005). This technique is vital in enzyme 
engineering to generate mutants with altered amino acid sequences in order to improve 
enzyme functional attributes (Urban et al., 1997, Xiao et al., 2007). 
 
1.1.3 (b) Engineering of mTGase  
Enzyme engineering is widely used to improve or alter the functional properties of 
mTGase over the past few years particularly for industrial purposes. Few publications 
have successfully showed improved mTGase properties including substrate specificity 
(Sugimura et al., 2008), thermostability (Marx et al., 2008b), activity (Yokoyama et 
al., 2010), and yield (Rickert et al., 2016) via various strategies.  
Both rational and random methods have been applied to screen for improved 
activity of mTGase by Yokoyama and his group. They started off with the rational 
mutagenesis by computing the percentage of solvent-accessibility surface area (SAS) 
of each amino acid in the activated mTGase. Forty amino acid residues with high 
values of SAS percentage was selected and subjected to SDM. Thirty two mutants 
exhibited a higher specificity than the wild type. For random mutagenesis, error prone 
PCR was applied to randomly mutate the whole region of the mTGase gene. Ten 
clones with higher specificity than the wild type were successfully isolated. Mutant 
S199A isolated from the random method demonstrated the highest specific activity, 
which was 1.7 times higher than the wild type (Yokoyama et al., 2010).  
Another group of researchers performed random mutagenesis on mTGase to 
generate thermostable and heat-sensitive variants for cross-linking at higher 
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temperatures. They observed all single point mutations which altered thermal 
properties of wild type mTGase were located at the N-terminal. One variant (S2P) 
demonstrated 270 % increase in the half-life after the serine residue near to the N-
terminal was mutated to proline (Marx et al., 2008b). In a separate case, mutagenesis 
on the pro-domain region was reported to affect the yield of soluble activated mTGase 
in E. coli cytoplasm. The rational approach was applied to perform alanine scanning 
on the pro-domain to identify mutants which are able to retain its chaperone function 
yet capable to be activated at a designated temperature. Alanine mutation at the pro-
domain region with an insertion of 3C protease expression successfully generated 
yields and enzymatic activities similar to wild type mTGase from S. mobarensis 
(Rickert et al., 2016). 
To reveal the substrate specificity of mTGase, researchers simulated a published 
three-dimensional docking model (PDB ID: 1IU4) with a peptide substrate, N-
Benzyloxycarbonyl-L-Glutaminylglycine (CBZ-Gln-Gly). Residues in the vicinity of 
Cys64 which interact frequently with CBZ-Gln-Gly were replaced with alanine by 
SDM. They observed significant reduction in mTGase activities after those sites were 
mutated to alanine (A). Also, they found that residues such as valine (V), leucine (L), 
isoleucine (I), phenylalanine (F), tyrosine (T), or tryptophan (W) in the vicinity of the 
glutamine (Q) residue are ideal to influence substrate recognition by forming 
hydrophobic interaction or Π-Π interaction (Tagami et al., 2009).  
Mutagenesis has been successfully applied in altering enzymes to introduce novel 
or improved properties. However, this approach often limits the success of designed 
mutations due to the basis of structure-function relationship. Therefore, the ability to 
carry out directed evolution of enzymes will provide a more systematic and high-
throughput approach to enzyme engineering. This will also involve the creation of 
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mutant libraries and screening for desired the target within these libraries in a high-
throughput manner. Therefore, display systems have been employed as an attractive 
alternative to generate a collection of variants with novel properties which can be 
screened and isolated simultaneously (Fernandez-Gacio et al., 2003). 
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1.1.4 Phage Display Technology  
Various display systems have been applied successfully to evolve enzymes 
including phage display (Fernandez-Gacio et al., 2003), ribosome display (Amstutz et 
al., 2002), mRNA display (Seelig, 2011), and bacterial display (Kim et al., 2000). 
Phage display technology is known as one of the best display systems for in vitro  
selection because it can handle large-sized libraries which increases the efficiency of 
screening for targets (Fernandez-Gacio et al., 2003). 
Phage display technology was first introduced by George Smith in 1985 to display 
peptides on the surface of phage particles as a fusion to the coat proteins (Smith, 1985). 
Presentation of peptides or proteins on phage surfaces allows for a  direct physical 
linkage between the phenotype and genotype as shown in Figure 1.4, making the 
identification of isolated particles convenient (Strachan et al., 2002, Garet et al., 2010). 
Figure 1.4: Structure of filamentous M13 bacteriophage and phage display biopanning. 
Biopanning process has four major steps. (1) Immobilisation of target on solid surface. 
(2) Incubation of phage library with the coated target. (3) Washing step to remove non-
specific/unbound phage. (4) Elution and amplification of bound phage. (5) The process 
is repeated by incubating the amplified phage with target. 
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Filamentous phages (f1, fd, M13) are commonly used in phage display systems to 
infect E. coli strains carrying the F’ episome due to their non-lytic characteristics 
(Tikunova and Morozova, 2009). Proteins or peptides are commonly displayed on 
phage surface by fusion to phage coat proteins pVIII (p8) and pIII (p3) (Hust and Dübel, 
2005, Vodnik et al., 2011). Even so, fusion to coat protein pVII (p7) (Kwaśnikowski 
et al., 2005, Løset et al., 2011b) and pIX (p9) (Løset et al., 2011a, Løset et al., 2011b) 
have also been reported. However, p3 is the preferred coat protein for display because 
it is the largest coat protein with 406 amino acids and able to display large proteins for 
selection (Zhao et al., 2016). 
The selection procedure via phage display technology to obtain specific proteins 
or peptides is known as biopanning which involves repetitive cycles of binding, 
washing, elution, and amplification of isolated phages (Figure 1.4). Generally, three to 
five rounds of biopanning are required to enrich high affinity predominant population. 
This allows clonal selection to define a concentrated pool of a particular population of 
clones with specific characteristics. Stringency of selection could be adjusted by 
varying the number of wash steps, condition of wash solution, incubation time of 
phages or concentration of target protein. After the last round of biopanning, selected 
phage clones are then identified with DNA sequencing since the genotype and 
phenotype are directly linked (Bazan et al., 2012, Lim and Chan, 2016). 
Previously, phage display was applied to display enzymes for selecting desired 
enzyme presenting phage clones based on catalytic activity (Fujita et al., 2005, 
Soumillion et al., 1994). However, the large molecular weight of enzymes often limits 
their maximum concentration in solution which results in long measurement times for 
low activities and background problem. Moreover, exportation of the bulky enzymes 
through the cytoplasmic membrane introduces another set of challenges. This is due 
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to the inefficiency of phage particles to present proteins that are large in size. In 
addition to that, selection for phage particles presenting enzymes based on catalytic 
activity is much more difficult than affinity based discrimination (Fernandez-Gacio et 
al., 2003). Therefore, these display formats are not widely used in enzyme engineering. 
Instead, phage display was applied successfully to select preferred substrates for 
enzymes. 
      Sugimura and his team identified preferred substrate sequences of mTGase via 
peptide phage display. The phage peptide library was first incubated with biotinylated 
cadaverine and mTGase. Then, samples were passed through an avidin column to 
isolate the desired peptide phages which are bound to the biotinylated cadaverine. The 
isolated peptide presenting phages were then proceeded with rounds of selection to 
enrich the desired peptide presenting phages. The group managed to enrich peptides 
with a consensus sequence which is different from mammalian TGases (Sugimura et 
al., 2008). An almost similar strategy was adopted to screen for preferred substrate for 
mTGase derived from Kutzneria albida (KalbTG). A 5-mer peptide library was 
constructed by using all combinations of 18 natural amino acids excluding cysteine 
and methionine or dimer, repeat of similar amino acid. Both N- and C-terminals of the 
5-mer peptides were flanked by a 3 amino acid linker. Peptide arrays were performed 
by incubating the peptide library with mTGase together with biotinylated cadaverine 
which was then detected with streptavidin labelled fluorescent dye. Motifs for both 
acyl donor and acyl acceptor were successfully identified and applied in protein 
labelling. Computational approach was later applied to superimpose KalbTG to 
mTGase derived from S. mobaraense to  predict the substrate binding mode (Steffen 
et al., 2017).  
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1.1.5 Computational Modelling for Protein 
Functional characterization of proteins based on sequence information is usually 
facilitated via three-dimensional (3D) structure to provide crucial structure-function 
information of a particular protein of interest. These structures can either be 
determined via experimental methods or computational methods. In experimental 
methods, X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy 
are the two most common approaches to determine 3D structures of proteins at high-
resolution (Webb and Sali, 2014, Madhusudhan et al., 2005). In the computational 
approach, the 3D structure of the protein of interest could be predicted via ab inito 
modelling or via comparative modelling by alignment with known protein structures 
(Baker and Sali, 2001, Fiser et al., 2002). The former is essential when similar 
structures are not available or unidentified, then models are built from scratch based 
on the laws of physics (Madhusudhan et al., 2005). Comparative modelling on the 
other hand predicts 3D structure of the protein (target) by alignment to proteins 
(template) with known structures (Webb and Sali, 2014).  
There are a few factors that needs to be considered when it comes to the selection 
of suitable templates for modelling. Firstly, the purpose of modelling has to be 
determined. For example, if a protein-ligand model is to be constructed, templates with 
similar ligands should be chosen. Next, sequence and subfamily similarity between 
target and template should be high to enable the selection of a template closest to the 
target to be modelled. Also, the environment between template and target including 
pH, ligands, solvent, quaternary interaction should be considered. Last but not least is 
the resolution and residual/reliability factor (R factor) of crystallographic structure. 
Higher resolution template should be used if two templates have comparable similar 
sequences with the target (Eswar et al., 2006). 
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Currently, MODELLER is one of the most popular choice for protein structure 
modelling experiments. Target sequences are inputs to be modelled based on template 
structures and MODELLER will automatically calculate a model without any user 
intervention (Eswar et al., 2006). Till today, two crystal structures of mTGase from S. 
mobaraensis (PDB ID: 1IU4; PDB ID: 3IU0) obtained by X-ray diffraction have been 
deposited in Protein Data Bank (PDB) (Kashiwagi et al., 2002, Yang et al., 2011). 
Both these crystal structures have provided valuable information for better 
understanding of mTGase especially in comparative modelling when property 
alteration is desired. Comparative model of mTGase from S. mobaraensis has not yet 
been reported so far. However, with the increase in number of crystal structures 
deposited in PDB, accuracy of comparative modelling is also improved to bridge the 
gap between known sequences with 3D model (Eswar et al., 2006, Fiser, 2010).  
 
 
 
 
 
 
